The Business Research Company Enjaymo Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The enjaymo ma ...

Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

When you have a rare disease such as cold agglutinin disease (CAD), you need to be diligent to avoid infections. One common infection I have seen over and over being discussed is a urinary tract ...

Discover how CoolSculpting permanently eliminates stubborn fat without surgery. Learn about the procedure, recovery time and ...

GBS is a rare, neuromuscular emergency that affects at least 150,000 people worldwide each year, with no FDA-approved therapy. The life-altering consequences of GBS were recently detailed in a new ...

Her laboratory results included a positive Coomb’s test with cold antibodies and a cold agglutinin titer of 256:1 ... she died in April 2024 due to disease progression. The authors noted that ...

and cold agglutinin disease (CAD), with slightly earlier programmes in haematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and amyotrophic lateral sclerosis ...